NTRK2 and obesity disorder: The present study demonstrated that fractalkine suppresses food intake via activation of the BDNF-TrkB pathway and that reduction of fractalkine-CX3CR1 signalling exacerbates HFD-induced hypothalamic inflammation and accelerates obesity in HFD-fed mice (Fig. 7g).